Cargando…
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
OBJECTIVE: This systematic review and meta-analysis aimed to evaluate whether dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate whether other comorbidities influence the association. METHODS: A systematic literature search using PubMed, Embase, and EuropePMC was...
Autores principales: | Atmosudigdo, Indriwanto Sakidjan, Lim, Michael Anthonius, Radi, Basuni, Henrina, Joshua, Yonas, Emir, Vania, Rachel, Pranata, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842489/ https://www.ncbi.nlm.nih.gov/pubmed/35173508 http://dx.doi.org/10.1177/1179551421990675 |
Ejemplares similares
-
WITHDRAWN: Dyslipidemia Increases the Risk of Severe
COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
por: Atmosudigdo, Indriwanto Sakidjan, et al.
Publicado: (2021) -
Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2021) -
The Association Between Chronic Kidney Disease and New Onset Renal Replacement Therapy on the Outcome of COVID-19 Patients: A Meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2020) -
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe
coronavirus disease-2019: a meta-analysis
por: Huang, Ian, et al.
Publicado: (2020) -
Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2021)